US Patent Issued to Purdue Research Foundation on Aug. 26 for "Fibroblast activation protein (FAP)-targeted imaging and therapy" (Indiana Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,069, issued on Aug. 26, was assigned to Purdue Research Foundation (West Lafayette, Ind.).

"Fibroblast activation protein (FAP)-targeted imaging and therapy" was invented by Philip Stewart Low (West Lafayette, Ind.) and Jyoti Roy (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present teachings relate generally to conjugates and methods for imaging a tumor microenvironment in a patient, and to conjugates and methods for imaging cancer-associated fibroblasts (CAFs) in the tumor microenvironment of a patient. The present teachings relate generally to method of making conjugates comprising a fibroblast activation protein (FAP) ...